熱門資訊> 正文
LifeMD任命新首席财务官;分享
2026-03-16 20:21
- LifeMD (LFMD) appointed Atul Kavthekar as chief financial officer effective March 16, replacing Marc Benathen.
- Benathen will remain with the company until March 31, 2026 to ensure a smooth leadership transition.
- LFMD shares up nearly 7% premarket.
More on LifeMD
- LifeMD: Wegovy Pill, Net Cash, And Low Multiple Sets Up Longs For Possible Alpha
- LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript
- LifeMD, Inc. 2025 Q4 - Results - Earnings Call Presentation
- LifeMD soars as Cantor Fitzgerald reportedly reiterates Overweight rating following solid Q4 print
- LifeMD outlines $250M+ annualized revenue run rate target by Q4 2026 amid record GLP-1 demand and expanded partnerships
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。